Mahbubur Rahman further said that hopefully within 1-1.5 weeks, Bangladesh will receive a batch of Sinopharm vaccine.
Meanwhile, Indonesia's drug regulator on Friday approved the COVID-19 vaccine of China's Sinopharm, which it will use in a private immunisation scheme where companies buy government-procured vaccines to inoculate their staff.
After Sinovac Biotech (SVA.O) and AstraZeneca (AZN.L), Sinopharm is the third company to have its vaccine approved by Indonesia, which is seeking to inoculate 181.5 million people by January 2022.
WHO to assess Chinese vaccines
"We do have an advisory group meeting today, and it will meet the next days to assess Sinopharm," said Mariangela Batista Galvao Simao, WHO assistant director-general for access to medicines and health products, at a briefing on Monday.
"We will be assessing Sinovac" on May 05, she said, adding "we expect that for Sinopharm we will have a decision before the end of this week, and Sinovac most likely by the end of next week."
"What we have been told by the WHO is that it will come in the first week of May... So if that is the case, we have at hand around 600,000 (of course we have used around 4,000 of those for Chinese nationals here)... We have about roughly 590,000 plus vaccines which we can use on our own population, he added."